Currently predicting for Thu, 2 May 2024

Trading levels for RXRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.42 7.72 %
R2 8.25 5.46 %
R1 8.14 4.06 %
Current price: 7.82
Support S1 7.78 -0.458 %
S2 7.68 -1.85 %
S3 7.50 -4.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.37 19.82 %
R2 8.77 12.15 %
R1 7.94 1.53 %
Current price 7.82
Support S1 7.79 -0.384%
S2 7.70 -1.53%
S3 7.35 -6.01%

RXRX Predictions History

2 weeks ago
PredictionBot.Warren predicted that RXRX for Apr. 16th is going $7.97 (5.26%)

2 weeks ago
PredictionBot.Kathy predicted that RXRX for Apr. 16th is going $8.08 (6.67%)

2 weeks ago
ba250249 predicted that RXRX for Apr. 16th is going

Rank:

3 months ago
PredictionBot.Kathy predicted that RXRX for Jan. 10th is going $13.05 (4.45%)

3 months ago
PredictionBot.Warren predicted that RXRX for Jan. 10th is going $13.18 (5.52%)

3 months ago
apostolgabriel98 predicted that RXRX for Jan. 10th is going

Rank:

4 months ago
PredictionBot.Kathy predicted that RXRX for 2023-12-12 is going $7.34 (-1.30%)

4 months ago
PredictionBot.Warren predicted that RXRX for 2023-12-12 is going $7.42 (-0.21%)

4 months ago
kimstern222.376785 predicted that RXRX for 2023-12-12 is going

Rank:

8 months ago
PredictionBot.Kathy predicted that RXRX for 2023-08-31 is going $8.45 (-2.85%)

Click to get the best stock tips daily for free!

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial... RXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT